Sports
The outlook for employer-sponsored health insurance is grim, with experts predicting even higher costs in 2027, as recent trends worsen the situation.
Technology
The FDA has approved AbbVie's new oral medication for Parkinson's disease, marking a significant advancement in treatment options for patients.
Technology
GLP-1 drugs are now being marketed for general wellness rather than just obesity, while Merck and Daiichi face setbacks in cancer therapy approval.
Finance
Novo Nordisk blurs the line between medications and lifestyle enhancements with its GLP-1s, sparking debate over their true classification.
Technology
GLP-1 medications are shifting focus from medical obesity treatments to lifestyle products, reflecting a broader marketing strategy by companies like Novo Nordisk.
Technology
Recent cases reveal how AI technology can unintentionally facilitate bioweapons development, blurring the lines of scientific intent.
Technology
A recent discovery in the anatomy of the heart challenges established knowledge, revealing a previously unrecognized structure and its implications for stroke risk.
Technology
A U.N.-backed agency has partnered with 11 manufacturers to produce generic versions of Roche's flu treatment Xofluza, enhancing access in low-income nations.
Technology
Explore the implications of rising Chinese biotech development and the potential impact of FDA nominee Heidi Overton on U.S. drug regulation.
Technology
An Indonesian court's decision against patent evergreening signals a shift towards improved medicine access, resonating with patient advocates globally.
Technology
Kyverna's recent study shows promising, enduring autoimmune relief from its cell therapy, signaling a significant advancement in treatment options.
Technology
Heidi Overton's Senate hearing as FDA commissioner nominee underscores urgency in drug approvals, while states weigh Medicaid pricing choices.
Technology
Insurers are opposing Medicare's new proposal that alters how remote patient monitoring services are delivered, raising concerns over patient care management.
Finance
The U.S. faces its most significant measles outbreak in over three decades, with unvaccinated individuals suffering the worst consequences.
Technology
Gilead Sciences is ramping up its commitment to inflammation and immunology, crucial for its future growth alongside virology and oncology.